Intuitive Surgical (NASDAQ:ISRG) Lowered to Sell Rating by Deutsche Bank Aktiengesellschaft

Intuitive Surgical (NASDAQ:ISRG) was downgraded by research analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a research report issued on Monday, Marketbeat reports. They presently have a $440.00 price objective on the medical equipment provider’s stock, down from their previous price objective of $515.00. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential downside of 16.92% from the company’s current price.

Several other research firms also recently weighed in on ISRG. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. Finally, Citigroup restated a “buy” rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Trading Up 0.7%

ISRG stock opened at $529.60 on Monday. The company has a market capitalization of $189.82 billion, a P/E ratio of 82.62, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical has a twelve month low of $413.82 and a twelve month high of $616.00. The business has a 50 day simple moving average of $523.08 and a 200-day simple moving average of $538.95.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company earned $1.50 earnings per share. Research analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 16,543 shares of company stock worth $8,375,072 over the last quarter. 0.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in Intuitive Surgical in the fourth quarter valued at about $25,000. Chilton Capital Management LLC increased its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Global Financial Private Client LLC increased its position in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares during the last quarter. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical during the 1st quarter worth approximately $26,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.